3D Global Biotech (ROCO:6808) Total Stockholders Equity : NT$293.47 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is 3D Global Biotech Total Stockholders Equity?

3D Global Biotech's Total Stockholders Equity for the quarter that ended in Dec. 2023 was NT$293.47 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. 3D Global Biotech's Book Value per Share for the quarter that ended in Dec. 2023 was NT$5.17. The ratio of a company's debt over equity can be used to measure how leveraged this company is. 3D Global Biotech's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.04.

3D Global Biotech Total Stockholders Equity Historical Data

The historical data trend for 3D Global Biotech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3D Global Biotech Total Stockholders Equity Chart

3D Global Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

489.02

448.82

389.71

340.60

293.47

3D Global Biotech Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial							389.71	372.75	340.60	312.53	293.47

3D Global Biotech (ROCO:6808) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

3D Global Biotech's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(293.467	-	0)	/	56.809
	=	5.17

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

3D Global Biotech's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.297	+	4.082)	/	293.467
	=	0.04

3D Global Biotech Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of 3D Global Biotech's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

3D Global Biotech (ROCO:6808) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3D Global Biotech Inc (ROCO:6808) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.99, Sec. 1, Xintai 5th Rd, 21st Floor -3, Xizhi District, New Taipei, TWN, 221

Website

http://www.3dglobalbiotech.com.tw

3D Global Biotech Inc is engaged in developing reconstruction of human tissues and organs and manufactures customized and personalized high-level medical devices.

3D Global Biotech (ROCO:6808) Headlines

No Headlines